Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Begins Trading on OTCQX®

V.BTI, OTCM

NEW YORK, Feb. 24, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that biOasis Technologies Inc. (TSX.V: BTI; OTCQX: BIOAF), a Vancouver-based biopharmaceutical company focused on developing a proprietary brain delivery platform ("Transcend") to enable existing and create new drugs that address unmet medical needs in the treatment of brain diseases, has been approved to trade on OTCQX®, the best marketplace with qualified companies.

OTC Markets Group logo.

biOasis begins trading today on OTCQX International, a segment of the OTCQX marketplace reserved for high-quality non-U.S. companies that are listed on a qualified international exchange and provide their home country disclosure to U.S. investors.  U.S. investors can find current financial disclosures and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"We are pleased biOasis has chosen to trade on OTCQX," said R. Cromwell Coulson, President and CEO of OTC Markets Group.  "biOasis is focusing on developing solutions to one of the most important medical challenges of our century: central nervous system disorders, including brain cancer.  We look forward to working with biOasis' management team as they continue to execute on their strategic goals and maximize the value of their public trading."  

"Within the past few years we've made some significant advancements around our Transcend platform, such that in the last eighteen months we have attracted four top tier Pharmaceutical companies to enter into collaboration agreements with us.  In addition to this, we've show in preclinical animal models that using Transcend we can deliver many of the potentially hundreds of the therapeutic biologics and small molecule drugs across the BBB to potentially treat a host of neurological diseases that are currently very problematic to treat, simply due to the brains protective barrier (BBB)," said Rob Hutchison Chairman and CEO of biOasis.  "Our move to the OTCQX is an important step for us as we are now ready to commence executing on our global strategy within our biotech/biopharmaceutical sector.  We firmly believe this will help us tell our story more widely within the investment community not only in the U.S., but globally."     

Sanders Ortoli Vaughn-Flam Rosenstadt LLP serves as biOasis' Principal American Liaison ("PAL") on OTCQX, responsible for providing professional guidance on OTCQX requirements and U.S. securities laws.

biOasis Technologies Inc. is a biopharmaceutical company headquartered in Vancouver, Canada.  Based on Transcend, biOasis proprietary brain delivery platform, the company is focused on creating new drugs that can cross the blood-brain barrier to address unmet medical needs in the treatment of brain diseases such as neurodegeneration, metastatic cancer and metabolic diseases.  For more information about the company please visit www.bioasis.ca.

biOasis will trade in the U.S. on OTCQX under the symbol "BIOAF."

About OTC Markets Group Inc. 
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace with Qualified Companies; OTCQB®, The Venture Stage Marketplace with U.S. Reporting Companies; and OTC Pink®, The Open Marketplace with Variable Reporting Companies. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link® ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

Logo: http://photos.prnewswire.com/prnh/20110118/MM31963LOGO

SOURCE OTC Markets Group Inc.